United States News All stories

Accenture (NYSE:ACN) has agreed to acquire Alfahealth, a digital health subsidiary of Engineering Group, to expand its healthcare capabilities in Italy by adding 1,200 specialized professionals.

Stellantis (NYSE:STLA), Wayve, and Uber (NYSE:UBER) partnered to deploy Level 4 driverless robotaxis across global consumer markets.

Dell Technologies (NYSE:DELL) declared a quarterly cash dividend of $0.63 per common share.

This distribution matches the company's ongoing capital return metrics from the previous quarter.

Tigo Energy (NASDAQ:TYGO) has begun shipping its new modular residential battery systems to customer accounts across Europe.

Teledyne Technologies (NYSE:TDY) launched its CheMSense Protect air monitor to detect chemical threat agents in under 20 seconds.

Rivian Automotive (NASDAQ:RIVN) announced a new round of layoffs this week as the electric vehicle maker attempts to streamline operations and reduce costs.

WeRide (NASDAQ:WRD) has partnered with Uber (NYSE:UBER) to launch a commercial robotaxi service in the Greater Zurich Region in 2026.

SpaceX raised US$75 billion by selling about 555 million shares at US$135 each, valuing the company near US$1.8 trillion and making Elon Musk a paper trillionaire.

A US–Iran peace agreement to halt nearly four months of fighting, including in Lebanon, sent oil lower and global stocks higher as markets priced in a planned Friday signing.

Elon Musk’s net worth briefly hit about US$1.4 trillion, momentarily exceeding bitcoin’s roughly US$1.31 trillion market value after SpaceX shares jumped 67% above their IPO price.

Spero Therapeutics (NASDAQ:SPRO) and GSK (NYSE:GSK) announced on June 17, 2026, that the FDA has granted approval for Utebzi, an oral antibiotic designed for adults with complicated urinary tract infections (cUTIs).

General Motors (NYSE:GM) and Lockheed Martin (NYSE:LMT) launched a partnership to expand U.S. defense production capacity.

Innoviva (NASDAQ:INVA) partnered with Dr. Reddy’s Laboratories (NYSE:RDY) to commercialize antibiotic XACDURO across four international territories.

One Stop Systems (NASDAQ:OSS) announced an initial $8.4 million defense contract to supply high-performance computing servers.

Yum! Brands (NYSE:YUM) executed definitive agreements to sell its Pizza Hut restaurant brand for $2.7 billion in the aggregate.

Allergan Aesthetics (NYSE:ABBV) received U.S. FDA approval for SKINVIVE neck treatments as its second product indication.

Swvl Holdings (NASDAQ:SWVL) announced its financial results for the three months ended March 31, 2026, revealing a substantial 68% year-over-year increase in total revenue to $8.2M.

Clinical-stage biotech company Clearmind Medicine (NASDAQ:CMND) has successfully completed the dosing of all 24 healthy participants in Part A of its FDA-regulated Phase I/II trial evaluating its proprietary compound, CMND-100, for the treatment of Alcohol Use Disorder.

Solana Company (NASDAQ:HSDT) rejected an unsolicited all-stock acquisition proposal from Forward Industries (NASDAQ:FWDI) valuing the business at $1.48 per share.

Clinical-stage biopharmaceutical firm HCW Biologics (NASDAQ:HCWB) reported positive preliminary human data from its Phase 1 trial of HCW9302, revealing that all three mild alopecia areata patients in the 3 μg/kg cohort achieved a 25% or greater reduction in SALT scores.

NovaBridge Biosciences (NASDAQ:NBP) received FDA Fast Track Designation for its bispecific antibody givastomig to treat advanced gastric adenocarcinoma expressing Claudin 18.2 protein levels.

Trinity Biotech (NASDAQ:TRIB) secured new purchase orders for over 2 million HIV tests to support its annual financial objectives.

Zai Lab (NASDAQ:ZLAB) has received European orphan drug designation for its antibody-drug conjugate targeting 375,000 annual lung cancer cases.

Nebius (NASDAQ:NBIS) completed its corporate acquisition of model optimization developer Eigen AI on June 10, 2026.